Question explored with the scientific record
Conversation so far
- 1 What causes very high blood calcium levels in dogs?
- 2 Can daily prednisone make a dog dying from cancer seem completely normal?
- 3 How can I tell if symptoms are masked vs the cancer improving?
Answered on this page ↓
How can I tell if symptoms are masked vs the cancer improving?
The real way to tell is by checking what happens when the prednisone dose drops, and by following objective scans rather than how the dog feels.
Prednisone suppresses inflammation, pain, fever, and appetite loss by blocking the chemical signals that cause those symptoms [2]. When a dog on prednisone seems normal, you cannot tell whether the cancer has shrunk or is just being masked. The key test is the dose reduction. If symptoms return when the prednisone is tapered, you are seeing masking. If they stay away, the cancer may truly be improving.
In one human case, a patient had a good clinical response to prednisone, but symptoms returned as soon as the dose was lowered [1]. In a veterinary study of dogs with relapsed lymphoma on a prednisone-containing protocol, the median progression-free survival was only 56 days for dogs that responded at all [3]. The drug gave temporary symptom control but the cancer kept progressing.
The only reliable way to distinguish masking from real improvement is with objective imaging or blood work. For lymphoma in dogs, that means checking lymph node size by physical exam and, where available, by ultrasound or CT. For other cancers, repeat imaging at intervals tells you whether the tumor is stable, shrinking, or growing. If you are relying on how the dog acts alone, you cannot tell the difference.
My call: dose tapering and objective imaging are the only ways to tell masking from true improvement. Confidence in this is high.
Sources used 3
-
Bioequivalent doses of budesonide and prednisone in moderate and severe asthma
This study compares the antiasthmatic and systemic glucocorticoid potencies of inhaled budesonide and oral prednisone in 34 adult asthma patients, finding that both drugs are equally effective at sufficient dosages, but budesonide has a more favorable safety profile.
DOI: 10.1016/0091-6749(89)90297-2 -
Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids
Combination therapy with tocilizumab, lenalidomide, and glucocorticoids induced complete remission in a patient with idiopathic multicentric Castleman disease (iMCD), with remission maintained for over 20 months.
DOI: 10.1097/md.0000000000017681 -
Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs
Vincristine-free MOPP-like salvage chemotherapy (MPP) yields a 34% overall response in dogs with resistant lymphoma, with predominantly mild toxicity, suggesting potential for dose intensification or combining with another agent.
DOI: 10.1111/j.1476-5829.2008.00170.x